Abemaciclib in combination with fulvestrant in patients with HR+/HER2-advanced breast cancer that had exhibited primary or secondary resistance to prior endocrine therapy

Affiliation auteurs!!!! Error affiliation !!!!
TitreAbemaciclib in combination with fulvestrant in patients with HR+/HER2-advanced breast cancer that had exhibited primary or secondary resistance to prior endocrine therapy
Type de publicationJournal Article
Year of Publication2019
AuteursFoster C., Pivot X., Llombart-Cussac A., Neven P., Lin Y., Kaufman P.A, Sledge JGW
JournalONCOLOGY RESEARCH AND TREATMENT
Volume42
Pagination289-290
Type of ArticleMeeting Abstract
ISSN2296-5270